Windward BIO's IPO
Filed Oct 23, 2026 (Form F-1). No terms yet. Applied to list on Nasdaq as WWB.
Breakaway does the work for you: insider and Congress trades, the chart, and the financials, in one score.
Once Windward BIO lists, Breakaway scores it against every US stock
- Its Quality Score from its second session, ranked against 3,191 stocks
- Every insider trade, the day it is filed
- The lock-up's end on your calendar, once the prospectus dates it
- An alert when its score is first set, and when it turns
See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.
What does Windward BIO do?
“We are a clinical-stage biotechnology company developing ultra-long-acting antibody medicines for patients with serious respiratory and dermatologic diseases, including asthma, chronic obstructive pulmonary disease, or COPD, and atopic dermatitis.”
| Fact | Windward BIO |
|---|---|
| Founded | 2024 |
| Employees | 38, as of September 30, 2026 |
| Website | windwardbio.com |
What is the offering?
Each figure names the filing it is from and that filing's date. The market cap is Breakaway's arithmetic from the prospectus's share count.
| Fact | Windward BIO |
|---|---|
| Underwriters | Jefferies, TD Cowen, Piper Sandler, and UBS |
| Exchange | Nasdaq Global Market, as WWB (applied to list) |
What the filing says about its money
| Fact | Windward BIO |
|---|---|
| Revenue | None from product sales yet |
| Cash | $207 million, as of June 30, 2026 |
| Last preferred stock | Series B preferred |
What risks does Windward BIO name first?
- “We are a clinical-stage biopharmaceutical company with a limited operating history, which may make it difficult to evaluate our current business and predict our future success and viability.”
- “We have incurred significant financial losses since our inception and anticipate that we will continue to incur significant financial losses for the foreseeable future.”
- “Even if this offering is successful, we will require additional funding in order to finance operations.”
Every date of Windward BIO's IPO
| What | Day |
|---|---|
| Registration filed | Oct 23, 2026 |
| Lock-up | 180 days |
The other IPOs expected
| Company | Price |
|---|---|
| $19 to $21 | |
| $15 to $17 | |
| $15 to $17 | |
| $7 | |
| $5 to $7 |
Windward BIO IPO questions
When is Windward BIO's IPO?
Filed Oct 23, 2026 (Form F-1). No terms yet. Applied to list on Nasdaq as WWB.
What is Windward BIO's IPO price?
Windward BIO has not set a price range yet; its Form F-1 of Oct 23, 2026 leaves it blank.
Who are the underwriters?
Jefferies, TD Cowen, Piper Sandler, and UBS, as the prospectus's cover names them.
When does the lock-up end?
Its prospectus sets a lock-up of 180 days; the day it ends is read from its final prospectus once it lists.
Does Breakaway rate Windward BIO?
Breakaway scores a new stock from its second trading day, ranked against every US stock it scores. For its first 21 sessions the page says New listing in place of the tier, and each check that needs more history waits for it.
Can Breakaway say where Windward BIO's price will go?
No. Breakaway does not say where a price will go. Every figure here is from the company's SEC filings, linked on each line.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Once Windward BIO lists, Breakaway scores it against every US stock
- Its Quality Score from its second session, ranked against 3,191 stocks
- Every insider trade, the day it is filed
- The lock-up's end on your calendar, once the prospectus dates it
- An alert when its score is first set, and when it turns
See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.